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Abstract
Background:  The homeodomain transcription factor IPF1/PDX1 exerts a dual role in the
pancreas; Ipf1/Pdx1 global null mutants fail to develop a pancreas whereas conditional inactivation
of Ipf1/Pdx1 in β-cells leads to impaired β-cell function and diabetes. Although several putative
target genes have been linked to the β-cell function of Ipf1/Pdx1, relatively little is known with
respect to genes regulated by IPF1/PDX1 in early pancreatic progenitor cells.
Results: Microarray analyses identified a total of 111 genes that were differentially expressed in
e10.5 pancreatic buds of Ipf1/Pdx1-/- embryos. The expression of one of these, Spondin 1, which
encodes an extracellular matrix protein, has not previously been described in the pancreas.
Quantitative real-time RT-PCR analyses and immunohistochemical analyses also revealed that the
expression of FgfR2IIIb, that encodes the receptor for FGF10, was down-regulated in Ipf1/Pdx1-/-
pancreatic progenitor cells.
Conclusion:  This microarray analysis has identified a number of candidate genes that are
differentially expressed in Ipf1/Pdx1-/- pancreatic buds. Several of the differentially expressed genes
were known to be important for pancreatic progenitor cell proliferation and differentiation
whereas others have not previously been associated with pancreatic development.
Background
The pancreas is an endodermally derived organ that forms
from a ventral and a dorsal evagination of the foregut epi-
thelium. These two evaginations, the dorsal and ventral
pancreatic buds, subsequently grow, branch and differen-
tiate into distinct pancreatic cell types [1]. The homeodo-
main transcription factor Insulin Promoter Factor 1/
Pancreatic and Duodenal homeobox 1 (IPF1/PDX1) is
one of the earliest markers of the developing pancreas.
IPF1/PDX1 is expressed already at ~10 somites stage at the
regions of the dorsal and ventral gut endoderm from
which the pancreatic buds evaginate [2]. IPF1/PDX1
expression remains high in pancreatic epithelial cells until
~e10.5 after which it is down-regulated [3] and remains
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low in proliferating pancreatic epithelial cells. Strong
IPF1/PDX1 expression reappears in the differentiating β-
cells as they emerge at ~e13 [3] and high level of IPF1/
PDX1 expression is maintained in adult β-cells where
IPF1/PDX1 controls the expression of several key β-cell
genes, including the insulin gene, thereby ensuring nor-
mal β-cell function and glucose homeostasis [4,5].
Loss of Ipf1/Pdx1  gene function in mice and humans
results in pancreatic agenesis demonstrating a key role for
the Ipf1/Pdx1 gene in pancreatic development [6-8]. Ipf1/
Pdx1 is, however, not required for the initiation of the
pancreatic program and the initial stages of pancreas
development, i.e. the formation of the pancreatic buds,
still occurs in Ipf1/Pdx1-/- mice [7,9]. Although the pancre-
atic program is initiated in Ipf1/Pdx1 deficient embryos,
the subsequent growth of the embryonic pancreas is
arrested, resulting in pancreas agenesis [6,7,9]. Recombi-
nation experiments between pancreatic epithelium and
pancreatic mesenchyme have demonstrated that the pan-
creatic developmental defect observed in Ipf1/Pdx1-/-
embryos is confined to the epithelial cells [9]. Thus, pan-
creatic mesenchyme isolated from Ipf1/Pdx1-/- e10.5 dor-
sal pancreatic buds could support the growth of wt e10.5
dorsal pancreatic epithelium whereas the reverse combi-
nation failed to grow [9]. These data provide evidence for
a cell-autonomous role for Ipf1/Pdx1 in early pancreatic
progenitor cells. To date, no direct or indirect Ipf1/Pdx1
downstream genes have, however, been identified that
can explain the pancreatic phenotype observed in Ipf1/
Pdx1-/- embryos.
To identify Ipf1/Pdx1 target genes in early pancreatic pro-
genitor cells and to begin to unravel the molecular mech-
anisms that lead to the attenuation of pancreatic growth
in Ipf1/Pdx1-/- mice we performed microarray analyses on
cDNA prepared from Ipf1/Pdx1-/- e10.5 buds and stage
matched littermate wildtype controls. We have identified
genes that are differentially expressed in Ipf1/Pdx1-/- pan-
creatic buds and a subset of these was chosen for further
expression analysis by quantitative real-time (qRT) RT-
PCR, in situ hybridization and immunohistochemistry. In
agreement with the pancreatic developmental defect
observed in Ipf1/Pdx1-/- embryos, several of the differen-
tially expressed genes identified in this study encode fac-
tors linked to pancreatic progenitor cell proliferation and
differentiation.
Results
Gene expression changes in Ipf1/Pdx1-/- pancreatic buds
In order to identify candidate Ipf1/Pdx1  downstream
genes in early pancreatic progenitor cells, dorsal pancre-
atic buds were isolated from e10.5 Ipf1/Pdx1-/- and Ipf1/
Pdx1+/+ littermate embryos. cDNA was prepared from pan-
creatic buds derived from 4 independent Ipf1/Pdx1-/- and 4
independent Ipf1/Pdx1+/+ littermates respectively, labeled
and hybridized to two different sets of microarrays. The
first contain approximately 15,000 clones obtained
through large-scale, in-house EST sequencing of three
cDNA libraries originating from a neural tissue stem cell
compartment (lateral ventricular wall), neurospheres
(neural stem cells cultured in vitro), and a hematopoietic
stem cell line expressing the Lhx2 gene [10]. The second
cDNA array used in this study contains 20,600 clones
derived from two different clone sets: a 15,000 mouse
cDNA set from National Institute of Aging (NIH) and a
5,400 cDNA clone set obtained from Research Genetics.
Genes that showed a change in expression that was two-
fold or more and had sufficiently high test-statistics were
considered to be differentially expressed (see Methods for
details). The microarray analyses revealed a total number
of 111 genes that were differently expressed. Of these 73
were down-regulated (Table 1) and 38 were up-regulated
(Table 2) in e10.5 dorsal pancreatic buds of Ipf1/Pdx1
deficient mice as compared to that of stage matched
wildtype littermates.
Altered expression of genes associated with cell 
proliferation and differentiation
Given the pancreatic growth arrest phenotype of Ipf1/
Pdx1-/-  mice we selected a total of 10 differentially
expressed genes identified by the microarray (9 down-reg-
ulated and 1 up-regulated) that encode factors linked to
growth and differentiation for further expression analyses
and validation by quantitative real-time RT-PCR. The
selected genes include genes previously associated with
pancreatic progenitor cell proliferation and differentia-
tion, including NK6 transcription factor related, locus 1
(Nkx6.1),  v-erb-b2 erythroblastic leukemia viral oncogene
homolog 3 (ErbB3), Secreted phosphoprotein 1 (Spp1) and
Paired box gene 6 (Pax6), as well as genes encoding factors
that previously have not been linked to pancreas develop-
ment, such as Spondin 1 (Spon1), Microsomal glutathione S-
transferase 1 (Mgst1), Reticulon 1 (Rtn1), Basic leucine zipper
nuclear factor 1 (Blzf1), Schwannomin interacting protein 1
(Schip1), and Secreted frizzled related protein1 (Sfrp1).
In agreement with the microarray data and previous find-
ings [11], the expression of the Nkx6.1, which encode a
homeodomain transcription factor that alike Ipf1/Pdx1 is
expressed in pancreatic progenitors and later in pancreatic
β-cells [12-15], was virtually undetectable in e10.5 Ipf1/
Pdx1-/-  dorsal pancreatic buds (Fig. 1). Immunohisto-
chemical analyses confirmed the loss of Nkx6.1 expres-
sion in e10.5Ipf1/Pdx1-/- dorsal pancreatic buds (Fig. 2a,
b). In contrast, the expression of the pan-endodermal
marker Foxa2 was normal in e10.5 Ipf1/Pdx1-/-dorsal pan-
creatic buds (Fig. 1) and Sox9 in situ hybridization clearly
depicted strong expression of Sox9 in both the dorsal and
ventral pancreatic buds in the mutant embryos (See Addi-BMC Developmental Biology 2007, 7:129 http://www.biomedcentral.com/1471-213X/7/129
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Table 1: Top ranked 73 down-regulated genes in Ipf1/Pdx1-/- vs. Ipf1/Pdx1 +/+ e10.5 dorsal pancreatic buds
Genbank acc. No. Gene Symbol Gene Name Fold-change
Extracellular matrix proteins
NM_009263 Spp1 secreted phosphoprotein 1 -9.8 U *
NM_033525 Npnt Nephronectin -6.1 U
NM_145584 Spon1 spondin 1, (f-spondin) extracellular matrix protein -3.8 K **
Transport
NM_172479 Slc38a5 solute carrier family 38, member 5 -8.8 U
NM_011401 Slc2a3 solute carrier family 2 (facilitated glucose transporter), member 3 -2.6 K
NM_009593 Abcg1 ATP-binding cassette, sub-family G (WHITE), member 1 -2.3 U
Signaling
NM_018763 Chst2 carbohydrate sulfotransferase 2 -4.5 U
XM_618828 Erbb3 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) -3.2 U *
NM_019946 Mgst1 microsomal glutathione S-transferase 1 -3.2 K *
NM_152815 Lins2 Lines homolog 2 (Drosophila) -2.4 U
NM_025505 Blzf1 basic leucine zipper nuclear factor -2.0 K
Transcription factors
NM_013627 Pax6 paired box gene 6 -5.8 K *
NM_144955 Nkx6-1 Nkx transcription factor related, locus 1 (Drosophila) -4.2 U ***
NM_008686 Nfe2l1 nuclear factor, erythroid derived 2,-like 1 -2.6 U
NM_010938 Nrf1 nuclear respiratory factor 1 -2.2 U
Cell adhesion
NM_008532 Tacstd1 tumor-associated calcium signal transducer 1 -3.2 U
NM_009864 Cdh1 cadherin 1 -2.6 U
Cell cycle
NM_013928 Schip1 schwannomin interacting protein 1 -3.1 K+U
NM_007631 Ccnd1 cyclin D1 -2.6 U
DNA binding
NM_198169 Gmeb2 glucocorticoid modulatory element binding protein 2 -2.9 U
NM_175074 Hmgn3 high mobility group nucleosomal binding domain 3 -2.4 K
Kinases/Phosphatases
NM_152804 Plk2 polo-like kinase 2 (Drosophila) -2.9 K
NM_011950 Mapk13 mitogen activated protein kinase 13 -2.5 U
NM_008981 Ptprg protein tyrosine phosphatase, receptor type, G -2.4 U
Apoptosis
NM_008410 Itm2b integral membrane protein 2B -2.3 U
Other
NM_026433 1810057C19Rik RIKEN cDNA 1810057C19 gene -6.3 U
NM_153457 Rtn1 reticulon 1 -6.1 U *
NM_018737 Ctps2 cytidine 5'-triphosphate synthase 2 -5.9 U
NM_007694 Chgb chromogranin B -5.9 K
NM_026238 Narfl nuclear prelamin A recognition factor-like -4.9 U
NM_145562 9130213B05Rik RIKEN cDNA 9130213B05 gene -4.8 U
NM_011255 Rbp4 retinol binding protein 4, plasma -4.2 U
NM_178747 Gulo gulonolactone (L-) oxidase -4.2 U
NM_025429 Serpinb1a serine (or cysteine) proteinase inhibitor, clade B, member 1a -4.2 U
AI451390 ESTs, transcribed locus -4.0 U
NM_133977 Trf Transferring -4.0 K
NM_009412 Tpd52 tumor protein D52 -3.8 U
NM_016962 Spast Spastin -3.5 U
NM_015784 Postn periostin, osteoblast specific factor -3.3 U
NM_133697 1110003E01Rik RIKEN cDNA 1110003E01 gene -3.2 UBMC Developmental Biology 2007, 7:129 http://www.biomedcentral.com/1471-213X/7/129
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tional file 1). These data demonstrate that the difference
in gene expression observed in wildtype and Ipf1/Pdx1-/-
dorsal pancreatic buds do not reflect a general decrease in
endodermally expressed genes. The expression of Pax6,
which encode a transcription factor expressed, and
involved, in pancreatic endocrine cell differentiation
[16,17] was reduced by ~69% in e10.5 Ipf1/Pdx1-/-dorsal
pancreatic buds (Fig. 1). Nevertheless, glucagon-express-
ing cells still appear in the Ipf1/Pdx1-/- mutant pancreas
([9] and Fig. 2) and glucagon expression was largely unaf-
fected in e10.5 Ipf1/Pdx1-/- dorsal pancreatic buds (See
Additional file 2), providing evidence that the remaining
Pax6 expression is sufficient to ensure glucagon expression.
The expression of ErbB3, a receptor of the EGF-family that
previously has been implicated in pancreatic growth
[18,19], was reduced by ~74% in e10.5 Ipf1/Pdx1-/- dorsal
pancreatic buds (Fig. 1). The expression of two genes
encoding extracellular matrix proteins, Spp1 and Spon1,
was reduced by ~91% and ~93%, respectively in e10.5
Ipf1/Pdx1-/-  dorsal pancreatic buds (Fig. 1). Spp1, also
known as osteopontin, is known to be expressed in the
fetal pancreatic epithelium and although Spp1 has been
implicated in cell adhesion and migration in several tis-
sues the pancreas develops normally in Spp1  deficient
mice [20-22]. Spon1 encodes the protein F-spondin that is
involved in proliferation of vascular SMC, neurite out-
growth and differentiation of neuronal precursor cells
[23-29]. The reduced expression of Spon1 in e10.5 pancre-
atic progenitor cells was confirmed by in situ hybridiza-
tion (Fig. 2c, d). The expression of Mgst1, which encode
an integral membrane protein involved in cellular
response to chemical or oxidative stress [30] and Rtn1,
which encodes a neuroendocrine-specific protein [31],
was reduced by 64% and 60%, respectively in e10.5 Ipf1/
Pdx1-/- dorsal pancreatic buds (Fig. 1).
In contrast, three genes, Blzf1, a gene up-regulated by
retinoids [32,33], Schip1, which is involved in cell cycle
regulation [34,35], and Sfrp1, which encode a secreted
antagonist to Wnt signaling [36], which all were identified
as differentially expressed in the microarray analysis could
not be validated when analyzed by quantitative real-time
NM_145599 Tmem34 transmembrane protein 34 -3.1 U
NM_025633 Metapl1 methionine aminopeptidase-like 1 -3.0 U
XM_125538 Sesn1 Sestrin 1 -3.0 K
NM_013471 Anxa4 annexin A4 -3.0 K
NM_008188 Thumpd3 THUMP domain containing 3 -2.8 U
NM_026323 Wfdc2 WAP four-disulfide core domain 2 -2.7 U
NM_033073 Krt2-7 keratin complex 2, basic, gene 7 -2.7 U
BB529246 ESTs -2.7 K
NM_178600 Vkorc1 vitamin K epoxide reductase complex, subunit 1 -2.6 U
NM_026524 Mid1ip1 Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)) -2.6 K+U
NM_008792 Pcsk2 proprotein convertase subtilisin/kexin type 2 -2.6 K
NM_013778 Akr1c13 aldo-keto reductase family 1, member C13 -2.6 K
NM_011464 Spint2 serine protease inhibitor, Kunitz type 2 -2.5 U
NM_197996 Tspan15 tetraspanin 15 -2.5 U
NM_022316 Smoc1 SPARC related modular calcium binding 1 -2.5 U
NM_019972 Sort1 sortilin 1 -2.4 U
NM_176860 2810457I06Rik RIKEN cDNA 2810457I06 gene -2.4 U
XM_133714 4921517J23Rik RIKEN cDNA 4921517J23 gene -2.4 K
NM_146057 Dap death-associated protein -2.4 K
NM_013492 Clu clusterin -2.3 U
NM_198654 4833432M17Rik RIKEN cDNA 4833432M17 gene -2.3 U
NM_138651 Cds2 CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 -2.2 U
NM_145991 Hrpt2 hyperparathyroidism 2 homolog (human) -2.2 U
NM_010485 Elavl1 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 -2.2 U
AI451897 ESTs, transcribed locus -2.2 U
NM_029341 Capsl calyphosine-like -2.2 K
NR_001592 H19 H19 fetal liver mRNA -2.1 U
XM_110660 AI427122 expressed sequence AI427122 -2.1 U
NM_025853 1700022L09Rik RIKEN cDNA 1700022L09 gene -2.1 U
NM_138606 Pim2 proviral integration site 2 -2.1 K
NM_031170 Krt2-8 Keratin complex 2, basic, gene 8 -2.0 U
NM_025975 Tcte1l t-complex-associated-testis-expressed 1-like -2.0 K
NM_007657 Cd9 CD9 antigen -2.0 K
K = changes obtained from the 15 K microarray. U = changes obtained from the 21 K microarray. * = validated by qRT RT-PCR. ** = validated by 
qRT RT-PCR and in situ hybridization. *** = validated by qRT RT-PCR and immunohistochemistry.
Table 1: Top ranked 73 down-regulated genes in Ipf1/Pdx1-/- vs. Ipf1/Pdx1 +/+ e10.5 dorsal pancreatic buds (Continued)BMC Developmental Biology 2007, 7:129 http://www.biomedcentral.com/1471-213X/7/129
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RT-PCR and were excluded from further analyses (data
not shown). Taken together, these data show that the
expression of several genes implicated in growth, differen-
tiation and adhesion, some of which have previously been
associated with pancreatic development, is impaired in
Ipf1/Pdx1-/- pancreatic progenitor cells.
Ptf1a/p48 and FgfR2IIIb expression is perturbed in Ipf1/
Pdx1-/- pancreatic buds
The expression of two genes, pancreas specific transcription
factor 1a/p48 (Ptf1a/p48) and fibroblast growth factor recep-
tor 2IIIb (FgfR2IIIb), that previously have been implicated
to have a role in pancreatic development [37-39] but
which were not spotted on the microarray chips were also
analyzed by quantitative real-time RT-PCR. FgfR2IIIb is
expressed in the developing pancreas and in FgfR2IIIb null
mutant mice pancreatic growth is reduced and the branch-
ing and morphogenesis of the pancreatic ductal epithe-
lium is impaired [39]. Quantitative real-time RT-PCR
analysis revealed that FgfR2IIIb expression was reduced by
~75% in e10.5 Ipf1/Pdx1-/- dorsal pancreatic buds com-
pared to that of stage matched Ipf1/Pdx1+/+ dorsal pancre-
Table 2: Top ranked 38 up-regulated genes in Ipf1/Pdx1-/- vs. Ipf1/Pdx1+/+ e10.5 dorsal pancreatic buds
Genbank acc. No Gene Symbol Gene Name Fold-change
Signaling
NM_009144 Sfrp2 secreted frizzled-related sequence protein 2 2.3 U
NM_175186 Lin9 lin-9 homolog (C. elegans) 3.6 U
NM_013834 Sfrp1 secreted frizzled-related sequence protein 1 3.7 K
Cell cycle
NM_026410 Cdca5 cell division cycle associated 5 2.2 U
Other
NM_011808 Ets1 E26 avian leukemia oncogene 1, 5' domain 2.0 K
NM_026421 2310057D15Rik RIKEN cDNA 2310057D15 gene 2.0 U
NM_145397 BC002059 cDNA sequence BC002059 2.1 U
NM_007896 Mapre1 microtubule-associated protein, RP/EB family, member 1 2.1 U
NM_010942 Nsg1 neuron specific gene family member 1 2.1 K
NM_134022 6330403K07Rik RIKEN cDNA 6330403K07 gene 2.1 K
BG075563 Dio3as deiodinase, iodothyronine type III, antisense 2.2 U
NM_010923 Nnat neuronatin 2.2 K
AI449753 AI449753 expressed sequence AI449753 2.2 U
NM_053197 Sfxn3 sideroflexin 3 2.2U
XM_620539 Trim6 tripartite motif protein 6 2.3 U
NM_177916 C230004F18Rik RIKEN cDNA C230004F18 gene 2.4U
NM_173750 2700007P21Rik RIKEN cDNA 2700007P21 gene 2.4 U
NM_024217 Cklfsf3 chemokine-like factor super family 3 2.4 U
NM_145629 Pls3 plastin 3 (T-isoform) 2.4 U
NM_007837 Ddit3 DNA-damage inducible transcript 3 2.4 U
NM_054082 Mta3 metastasis associated 3 2.5 U
NM_016797 Stx7 syntaxin 7 2.6 U
NM_008590 Mest mesoderm specific transcript 2.6 K
NM_011058 Pdgfra platelet derived growth factor receptor, alpha polypeptide 2.7 K
NM_012005 Crsp2 cofactor required for Sp1 transcriptional activation, subunit 2 2.7 U
AK037782 D130019J16Rik RIKEN cDNA D130019J16 gene 2.7 U
NM_025783 Vps24 vacuolar protein sorting 24 (yeast) 2.9 U
NM_001004155 9930012K11Rik RIKEN cDNA 9930012K11 gene 3.0 U
NM_146153 Thrap3 Thyroid hormone receptor associated protein 3 3.1 U
NM_175439 Mars2 methionine-tRNA synthetase 2 (mitochondrial) 3.2 U
NM_008865 Csh2 chorionic somatomammotropin hormone 2 3.2 U
NM_178631 0710005M24Rik RIKEN cDNA 0710005M24 gene 3.3 U
NM_019721 Mettl3 methyltransferase-like 3 3.3 U
NM_030704 Hspb8 heat shock 27 kDa protein 8 4.0 U
NM_177648 Tmem15 transmembrane protein 15 4.1 U
NM_178608 D6Ertd253e DNA segment, Chr 6, ERATO Doi 253, expressed 4.1 U
NM_024251 2010301N04Rik RIKEN cDNA 2010301N04 gene 4.1 U
NM_010910 Nefl neurofilament, light polypeptide 7.3 U
K = changes obtained from the 15 K microarray. U = changes obtained from the 21 K microarray.BMC Developmental Biology 2007, 7:129 http://www.biomedcentral.com/1471-213X/7/129
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atic buds (Fig. 1). Immunohistochemical analyses
confirmed the reduced expression of FGFR2IIIb in e10.5
pancreatic progenitor cells of Ipf1/Pdx1-/- deficient mice
(Fig. 2e, f).
PTF1a/p48 has been implicated in commitment and pro-
liferation of pancreatic progenitor cells and Ptf1a/p48-/-
null mutant mice fail to develop a pancreas [37,38].
Quantitative real-time RT-PCR analyses showed that
Ptf1a/p48 expression was reduced by ~91% in Ipf1/Pdx1-/-
e10.5 dorsal pancreatic buds as compared to wild-type lit-
termates (Fig. 1). In situ hybridization analyses confirmed
the reduced expression of Ptf1a/p48 in dorsal pancreatic
buds of Ipf1/Pdx1-/- embryos compared to wildtype litter-
mates (Fig. 2g, h). These results suggest that in early pan-
creatic progenitor cells both FgfR2IIIb and Ptf1a/p48 are
direct or indirect Ipf1/Pdx1 downstream target genes.
Spon1 expression in pancreatic progenitor cells overlaps 
temporally with the phase of proliferation
Spon1 encodes the extracellular matrix protein F-spondin,
also known as vascular smooth muscle cell growth-pro-
moting factor. F-spondin stimulates the proliferation and
growth of vascular SMC during ovarian growth and devel-
opment [28]. In addition, F-spondin has been reported to
promote neurite outgrowth from spinal chord, hippocam-
pal and sensory neurons [23,25,27] as well as the differen-
tiation of neural progenitor cells [29]. Spon1  has not
previously been described to be expressed in the develop-
ing pancreas. Thus, we next determined the temporal and
spatial expression of Spon1 in the developing pancreas by
in situ hybridization.
At e9.5 Spon1 expression was observed in epithelium of
the dorsal and ventral pancreatic bud (Fig. 3a and data not
Quantitative real-time RT-PCR validation of selected genes Figure 1
Quantitative real-time RT-PCR validation of selected 
genes. Expression analyses of the indicated genes using 
cDNA prepared from Ipf1/Pdx1+/+ (n = 4–9) and Ipf1/Pdx1-/- 
(n = 4–8) dorsal e10.5 pancreatic buds. Data represent mean 
values ± SEM. * p < 0.05; ** p < 0.01; *** p < 0.001 for Ipf1/
Pdx1+/+ versus Ipf1/Pdx1-/-.
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In situ and immunohistochemical analyses of differentially expressed genes Figure 2
In situ and immunohistochemical analyses of differentially expressed genes. Immunohistochemical analysis of 
wildtype (A and E) and Ipf1/Pdx1-/- mice (B and F) using antibodies against Nkx6.1 (red in A and B), FGFR2b (red in E and F) and 
glucagon (green in A, B, E and F). In situ hybridization of wildtype (C and G) and Ipf1/Pdx1-/- mice (D and H) using DIG-labeled 
Spon1 (red pseudocolor in C and D) and Ptf1a/p48 (red pseudocolor in G and H) probes counterstained with antibodies 
against glucagon (green in C, D, G and H). Scale bar 100 µm.BMC Developmental Biology 2007, 7:129 http://www.biomedcentral.com/1471-213X/7/129
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shown). Spon1 expression was maintained within the pan-
creatic epithelium of the developing pancreas until e15.5,
although the expression appeared reduced at this stage
(Fig. 3b–e). By e17.5 Spon1  expression was no longer
detectable within the pancreas (Fig. 3f). Throughout pan-
creatic development Spon1 expression was restricted to the
developing pancreatic epithelium and the forming acini
whereas no expression was observed in differentiated
endocrine cells (Fig. 3c, d). In contrast to IPF1/PDX1,
Spon1 was not expressed in the developing duodenal epi-
thelium (Fig. 3b and data not shown). These data imply
that additional transcription factors act to restrict Spon1
expression in the developing gastrointestinal tract and
also suggest that Spon1 may be used as a marker to distin-
guish between early pancreatic and duodenal cells.
Discussion
In Ipf1/Pdx1 deficient embryos, pancreatic development
becomes arrested around e10 [6,7,9] but the molecular
mechanism(s) underlying this early developmental arrest
has remained largely unknown. To begin to identify genes
regulated by Ipf1/Pdx1 in early pancreatic progenitor cells
that could help to explain the developmental arrest
observed in Ipf1/Pdx1 -/- embryos we embarked on a gene
array profiling and quantitative real-time RT-PCR
approach. Given the early developmental arrest and hence
limiting amount of tissue, i.e. dorsal buds from e10.5 Ipf1/
Spon1 is expressed in the developing pancreatic epithelium Figure 3
Spon1 is expressed in the developing pancreatic epithelium. A-F: In situ hybridization of e9.5 (A), e10.5 (B), e12.5 (C), 
e13.5 (D), e15.5 (E) and e17.5 (F) using a DIG-labeled Spon1 probe (green pseudo-color in A-B, red pseudo-color in C-D and 
black staining in E) counterstained with antibodies against IPF1/PDX1 (red in A-B) and glucagon (green in C-D). Scale bar 100 
µm.BMC Developmental Biology 2007, 7:129 http://www.biomedcentral.com/1471-213X/7/129
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Pdx1 +/+ and Ipf1/Pdx1 -/- litter pairs, that could be retrieved
for further cDNA synthesis we first performed a pilot
study using the 15 K cDNA chip that was hybridized twice
with cDNA prepared from dorsal buds of a matched Ipf1/
Pdx1 +/+ and Ipf1/Pdx1 -/- e10.5 litter pair.
This pilot study was followed by two hybridizations of the
15 K cDNA chip with cDNA prepared from another pair of
matched Ipf1/Pdx1 +/+ and Ipf1/Pdx1 -/- e10.5 dorsal buds.
The 21 K cDNA chip was originally hybridized with cDNA
from 4 pairs of Ipf1/Pdx1 +/+ and Ipf1/Pdx1 -/- e10.5 dorsal
buds in a standard manner. However due to technical
problems in the hybridization step one of the arrays had
to be excluded from the experiment resulting in a 3 arrays
from the 21 K experiment. In summary a total of 4 inde-
pendent pairs of Ipf1/Pdx1 +/+ and Ipf1/Pdx1 -/- e10.5 dorsal
buds were analyzed on four 15 K arrays and three 21 K
arrays.
Hence, there were some limitations in our microarray
study. We had a total of four biological replicates per con-
dition: the 15 K experiment used only 2 biological repli-
cates per condition and the 21 K experiment used 3
biological replicates per condition. This limitation was
due to challenges in retrieving sufficient tissue material for
subsequent cDNA synthesis. We analyzed separately the
data from the two arrays, so the results of these analyses
are based on a small number of biological replicates. Fur-
thermore, the experimental design was unbalanced in var-
ious ways (different types of technical replication in the
assays using the 15 K arrays, unbalanced dye assignments,
etc.). Thus, the list of differentially expressed genes identi-
fied solely by our microarray experiments might be sub-
optimal in terms of a bona fide candidate list. However, it
provided us with sufficient information for selecting
potentially interesting Ipf1/Pdx1 regulated genes that we
followed-up with quantitative real-time RT-PCR, in situ
hybridization and immunohistochemistry.
Here we show that the expression of FgfR2IIIb is reduced
in Ipf1/Pdx1-/- e10.5 pancreatic buds, thus linking IPF1/
PDX1 to FGF signaling in pancreatic progenitor cells. FGF
signaling has been shown to be important both for nor-
mal pancreas development and maintenance of pancre-
atic function in adults [5,40,41]. Mice with a targeted
disruption of Fgf10 show an early block in pancreas devel-
opment that is reminiscent of that observed in Ipf1/Pdx1
null mutant mice. Alike the Ipf1/Pdx1-/- mice the pancre-
atic program is initiated in Fgf10-/- mice, i.e. the evagina-
tion of the pancreatic buds occur, but the subsequent
proliferation and branching of the pancreatic epithelium
is perturbed [42]. Moreover, mice lacking the FGF10
receptor,  FgfR2IIIb, display a pancreatic growth defect
with impaired branching and morphogenesis of the duc-
tal epithelium. [39]. Moreover, forced expression of Fgf10
in the developing pancreatic epithelium results in pancre-
atic hyperplasia, adding further evidence for a role for
FGF10-FGFR2IIIb signaling in pancreatic progenitor cell
proliferation [40,41].
Taken together, the almost identical pancreatic phenotype
observed in mice lacking either Ipf1/Pdx1, the receptor
FgfR2IIIb, or Fgf10, and the reduced pancreatic expression
of FgfR2IIIb in Ipf1/Pdx1-/- embryos provide evidence for a
role for IPF1/PDX1 in regulating FGF signaling in the
developing pancreatic epithelium. Thus, Ipf1/Pdx1
appears to regulate pancreatic growth by ensuring high
level expression of FGFR2IIIb in pancreatic progenitor
cells. Interestingly, Ipf1/Pdx1 has also been shown to reg-
ulate the expression of another FGF-receptor, FGFR1c, in
adult β-cells thereby ensuring normal β-cell function and
glucose homeostasis [5].
Epidermal growth factor (EGF) signaling has also been
linked to pancreatic growth and development [1,19,43].
Several EGF receptors, including ErbB3, have been shown
to be expressed in the developing pancreatic epithelium
[19]. In addition, ErbB3  has been described to be
expressed in the pancreatic mesenchyme [18,19]. Mice
lacking a functional ErbB1/Egfr  gene have mildly per-
turbed pancreatic growth [44] and mice lacking a func-
tional  ErbB3  gene present with pancreatic hypoplasia
[18,44]. Additional support for a role of the EGF family in
pancreas development originates from in vitro studies in
which EGF was shown to stimulate the growth of e13.5 rat
pancreatic epithelium that had been depleted of mesen-
chyme [45]. Thus, in addition to the reduced expression
of FgfR2IIIb in progenitor cells of Ipf1/Pdx1 deficient mice
the reduced expression of ErbB3 is likely to contribute to
the perturbed pancreatic development that these mice
present with.
Ptf1a/p48 expression is severely reduced in Ipf1/Pdx1 null
mutant mice, providing evidence that Ptf1a/p48, directly
or indirectly, is a downstream target gene of Ipf1/Pdx1. In
support of a role for Ipf1/Pdx1  in regulating Ptf1a/p48
expression, inactivation of the Ipf1/Pdx1 gene in the pan-
creatic epithelium at progressively later stages also results
in reduced expression of Ptf1a/p48  [46]. In contrast,
Kawaguchi et al. have shown that transgenic expression of
Ipf1/Pdx1 under the control of the Ptf1a/p48 promoter in
an Ipf1/Pdx1-/- null background partially rescued the pan-
creatic developmental arrest [37], suggesting that Ptf1a/
p48 expression is independent of Ipf1/Pdx1. However, the
Ptf1a-Ipf1/Pdx1  transgenic rescue approach leaves open
the possibility that the partially rescued phenotype is the
result of leaky transgene expression due to positional inte-
gration effects and/or transgene copy number. Moreover,
since the hsp68 minimal promoter was coupled to the
Ptf1a/p48 promoter in the transgenic rescue approach, theBMC Developmental Biology 2007, 7:129 http://www.biomedcentral.com/1471-213X/7/129
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transgene expression may differ from that of the endog-
enous Ptf1a/p48 promoter.
Alike Ipf1/Pdx1, Nkx6.1 is expressed in pancreatic progen-
itors from embryonic day 9.5 and thereafter the expres-
sion of Nkx6.1 also becomes restricted to mature β-cells.
Nkx6.1 has previously been identified as a downstream
target gene of IPF1/PDX1; β-cell specific inactivation of
the Ipf1/Pdx1 gene resulted in a loss of Nkx6.1 expression
in β-cells [4,11] and in agreement with previous findings
[4,11] we show that Nkx6.1 expression is abolished also in
pancreatic progenitor cells of Ipf1/Pdx1 null mutant mice.
These data provide strong evidence that Ipf1/Pdx1  act
upstream of Nkx6.1 in both pancreatic progenitor cells
and adult β-cells.
F-spondin, encoded by Spon1, is a 90 kDa extracellular
matrix protein that has been reported to play an impor-
tant role in proliferation and growth of vascular SMC dur-
ing ovarian growth and development [28]. F-spondin has
also been showed to promote neurite outgrowth from spi-
nal chord, hippocampal, and sensory neurons [23,25,27].
Other reports describe a role for F-spondin in the develop-
ment of the nervous system where it is predominately
expressed during early stages of development but down-
regulated during neural differentiation [23]. F-spondin
has also been suggested to promote differentiation of neu-
ral precursor cells to nerve cell-like cells [29]. Interest-
ingly, a F-spondin related protein, R-spondin, has been
shown to function as a growth factor; injection of R-spon-
din in mice resulted in an increased proliferation of intes-
tinal crypt epithelial cells in both the small intestine and
colon [47]. Similar to the transient expression of Spon1 in
the developing nervous system, Spon1  is transiently
expressed, from e9.5 to e15.5 in progenitor cells of the
developing pancreas. Thus, Spon1 expression in the devel-
oping pancreas overlaps with the phase of pancreatic pro-
genitor cell proliferation. Whether F-spondin is involved
in regulation of proliferation and/or differentiation of
pancreatic progenitor cells will have to be determined by
functional analyses in vitro and/or in vivo.
Conclusion
Taken together, our data show that Ipf1/Pdx1, directly or
indirectly, regulates the expression of genes, such as Ptf1a/
p48, FGFR2IIIb, and ErbB3, implicated in pancreatic
growth and differentiation, providing evidence that the
perturbed expressions of these factors provide a mechanis-
tic explanation for the pancreatic developmental arrest
that Ipf1/Pdx1-/- mice present with. In addition we show
that Spon1, which encodes an extracellular matrix protein,
is expressed in the developing pancreas and that Spon1
expression is down-regulated in Ipf1/Pdx1-/- embryos.
Methods
Mice
The animal studies were approved by the Institutional
Animal Care and Use Committee of Umeå University and
conducted in accordance with the Guidelines for the care
and use of Laboratory Animals. The generation of Ipf1/
Pdx1-/- mice has been previously described [6]. Ipf1/Pdx1
wildtype and null mutant embryos were obtained from
our local breeding stock.
Isolation of embryos and tissue
Ipf1/Pdx1+/-  mice were mated and embryonic day 0.5
(e0.5) was determined by the presence of morning vaginal
plug. Pregnant females were sacrificed at e10.5 and
embryos were transferred to ice-cold Lebovitz L-15
medium (Gibco). Dorsal pancreatic buds were dissected
out in L-15 medium and snap frozen in liquid nitrogen
for later RNA isolation. Embryos sacrificed for immuno-
histochemistry and in situ hybridization were fixated in
4% paraformaldehyde (SIGMA) in 0.1 M PBS for 2 hours
and overnight respectively at +4°C followed by dehydra-
tion in 20% sucrose overnight at 4°C and mounted in Tis-
sue-Tek (Sakura) and stored at -80°C.
Genotyping
Genomic DNA was extracted from embryonic tails by pro-
teinase K (Boehringer) digestion followed by 2-propanol
precipitation. Genotyping was performed by PCR using
two internal Ipf1/Pdx1 primers; 5'-AGAAGCTGGCCACTA
GCCTCT-3' and 5'-CTGTGGGCAACAAGGGAGTT-3', and
two internal Neo primers; 5'-AGAAGCTATTCGGCTATGA-
3' and 5'-TTTCCACCATGATATTCG-3'. The PCR reactions
result in a 150 bp and a 548 bp product respectively if tar-
get sequence is present.
Microarray, hybridization and scanning
The cDNA microarrays used in this study were of two
types. The first contain approximately 15,000 clones
printed in duplicate, in two identical fields, yielding
30,000 probes. The set of probes represents approxi-
mately 12,000 unique genes obtained through large-scale,
in-house EST sequencing of three cDNA libraries. The first
library originates from a neural tissue stem cell compart-
ment (lateral ventricular wall), the second from neuro-
spheres (neural stem cells cultured in vitro) and the third
from a hematopoietic stem cell line expressing the Lhx2
gene [10]. The second cDNA array used in this study con-
tains 20,600 clones derived from two different clone sets:
a 15,000 mouse cDNA set from National Institute of
Aging (NIH) and a 5,400 cDNA clone set obtained from
Research Genetics. Microarray slides were hybridized at
42°C in a water bath for 16–20 hours (15 K array) or at
37°C in a Genetac hybridization station (Genomic Solu-
tions) for 15 hours (21 K array). The 15 K arrays were
scanned using the G2565BA DNA microarray scannerBMC Developmental Biology 2007, 7:129 http://www.biomedcentral.com/1471-213X/7/129
Page 10 of 12
(page number not for citation purposes)
(Agilent Technologies) and images analyzed in the
GenePix5.0 software (Axon Instruments, CA, USA). The
21 K arrays were scanned using the Scanarray 4000 XL
microarray scanner (Perkin Elmer) at three settings (laser
power/PMT): 80/80, 90/90 and 100/100 (in that order),
where the numbers were percentages of maximum values.
Images were analyzed using the ScanarrayExpress software
(Perkin Elmer).
RNA isolation, amplification and labeling
Total RNA was isolated from individual pancreatic buds
using Nucleospin RNA II kit (Clontech) according to
manufacturer's guidelines. cDNA was generated and
amplified using SuperSMART™ PCR cDNA synthesis kit
(Clontech). 2 µg of each cDNA preparation was labeled
with the fluorescent dyes Cy3 or Cy5 using BD Atlas™
SMART™ Fluorescent Probe Amplification kit (BD Bio-
sciences Clontech) according to manufacturer's recom-
mendations. Samples hybridized to the 15 K cDNA
microarrays were labeled and analyzed as follows: In the
first set, the labeled samples (one wildtype bud cDNA
labeled with Cy3, one Ipf1/Pdx1 null mutant pancreatic
bud cDNA labeled with Cy5) were split in two, and ana-
lyzed as duplicates on two separate microarrays. In the
second set, the samples (one wildtype bud cDNA and one
Ipf1/Pdx1 null mutant pancreatic bud cDNA) were split
before labeling, and analyzed as a dye-swapped replicate
on two separate microarrays.
Samples hybridized to the 21 K cDNA microarrays were
labeled and analyzed as follows: two wildtype and one
Ipf1/Pdx1 null mutant pancreatic bud were individually
labeled with Cy3 and two Ipf1/Pdx1 null mutants and one
wildtype pancreatic bud were individually labeled with
Cy5. Samples were pooled pair wise and hybridized to
three 21 K cDNA microarrays.
One wt cDNA sample and one Ipf1/Pdx1  null mutant
cDNA sample hybridized to the 21 K array were identical
to second set of samples hybridized to the 15 K array. Due
to the limited amount of material, the rest of the samples
were hybridized to one array each (15 K or 21 K array).
In total, cDNA generated from pancreatic buds from 4
individual Ipf1/Pdx1 null mutant and 4 wildtype litterma-
tes respectively were individually labeled, pooled pair
wise and hybridized to four 15 K cDNA microarrays and
to three 21 K cDNA microarrays.
Microarray data processing and statistical analysis
The 15 K and 21 K experiments were analyzed separately
as described below. Given some selection criteria, dis-
cussed below, 111 genes were considered differentially
expressed. 73 of these genes were down-regulated (Table
1) and 38 up-regulated (Table 2) in Ipf1/Pdx1  null
mutants. Additional information and all array data are
reported to ArrayExpress [48] with the following accession
numbers. [ArrayExpress: E-TABM-280] and [ArrayExpress:
E-MEXP-1047].
The 21 K microarray analyses were carried out using
ScanArrayExpress 2.1 (PerkinElmer) and the in-house S-
Plus library UmeaSAMED 1.39. The data analysis
included: combined image analysis extracting median
intensity values, complete filtration, local background
correction, RLS 100, removed C-spots, MA-print-tip nor-
malization with span = 0.5, censoring with minimum
value 8, and the B-test, see [49] for detailed descriptions
of the procedures. Genes with top-ranked B-statistics (top
100) and at least two-fold regulated (i.e. the absolute
value of the average log-ratio 1), were selected for further
studies.
The 15 K microarray analyses were carried out using R
(1.7), Bioconductor, LIMMA (1.3), and the aroma pack-
age [50-52]. Several filtering steps, normalization and sta-
tistical analyses were done, as detailed in ArrayExpress.
The foreground intensities without background subtrac-
tion were extracted using the median intensity values. A
feature was filtered if it was flagged as "Not Found" in
GenePix, if both channels were saturated, the percentage
of foreground pixels above the local background plus two
of its standard deviations were below 70 for both chan-
nels, or the signal-to-noise ratio for both channels were
below 3. Data was normalized using MA-print-tip nor-
malization [53]. The intensities for duplicated features
were averaged after normalization. The empirical Bayes
moderated t-test implemented in the LIMMA package (i.e.
the B-test) was used [54] to identify differentially
expressed genes [51]. The four 15 K assays were analyzed
in two separate sub-experiments, each including the two
assays derived from the same biological replicates. Genes
that were at least two-fold up-regulated (or down-regu-
lated) in both sub-experiments and had B-values larger
than 10 in sub-experiment 1 and 2 in sub-experiment 2
were selected for further studies.
Quantitative real- time RT-PCR
Gene expression levels were measured using the ABI
PRISM 7000 Sequence Detection System (Applied Biosys-
tems) according to the manufactures recommendations.
Expression of the β-2-microglobulin (b2M and TBP) was
used to normalize expression levels. Primer sequences
were the following: B2M: 5'-GCTATCCAGAAAACCCCT-
CAAA-3', 5'-CTGTGTTACGTAGCAGTTCAGTATGTTC-3';
Blzf1: 5'-ACAGCCCAGCTTTCTGAACAG-3', 5'-ACTCATC
TGCCATTACCCTGCTT'3'; ErbB3: 5'-CTCTCCCCACCAG-
GGTTAGAG-3', 5'-TGACGAAAGGGTCCCTTCC-3'; Fgfr2I
IIb: 5'-CAGTAAATACGGGCCTGATGG-3', 5'-GAACAGAG
CCAGCACTTCTGC-3';  Foxa2: 5'-GAGCCATCCGACT-BMC Developmental Biology 2007, 7:129 http://www.biomedcentral.com/1471-213X/7/129
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GGAGCA-3', 5'-GGAATGAGCCCGTCGCTAG-3'; Glu: 5'-
CCGCCGTGCCCAAGA-3', 5'-CATCATGACGTTTGGCAA
TGTT-3';  Ipf1: 5'-TAGGACTCTTTCCTGGGACCAA-3', 5'-
AATAAAAAGGGTACAAACTTGAGCGT-3'; Mgst1: 5'-CGC
ATTCCAGAGGATAACCAA-3', 5'-CAAAGCCAGCGCAG
TCTTCT-3'; Nkx6.1: 5'-TCAGGTCAAGGTCTGGTTCCA-3',
5'GGTCTCCGAGTCCTGCTT-3'; P48: 5'-TCATCTGCCAT
CGAGGCAC-3', 5'-ACCATAATCCGGGTCACTGG-3';
Pax6: 5'-GCAAACAACCTGCCTATGCAA-3', 5'-GGCAGC
ATGCACGAGTATGA-3'; Reticulon: 5'-CCTGGTCCAGAC-
CTGGTG-3', 5'-AGCCACATGAGGACTGCAAAT-3';
Schip1:  5'-AAAAAGTCTCCCGTCGCTGA-3', 5'-TTCGCT-
TATGTGAGGCATGTGT-3'; Sfrp1: 5'-CCTCCATGCGA
CAACGAGTT-3', 5'-TTGATTTTCATCCTCAGTGCAAAC-
3'; Spondin1: 5'-GAAGCAGCTACCGAGTGACACTT-3', 5'-
CTTTGAGGGCAATTAACGTGAAA-3'; Spp1: 5'-TCAAAG
TCTAGGAGTTTCCAGGTTTC-3', 5'-TGTGGCATCAGGA-
TACTGTTCATC-3'; TBP: 5'-GAATTGTACCGCAGCTTCAA
AA-3', 5'-AGTGCAATGGTCTTTAGGTCAAGTT-3'.
Immunohistochemistry
Immunohistochemistry was performed as described [9].
Primary antibodies used were: rabbit anti-IPF1/PDX1 [3],
rabbit Nkx6.1 [40], rabbit anti-FgfR2 (Research Diagnos-
tics, Inc) and glucagon anti-guinea pig (Electra-Box Diag-
nostika Ab). Secondary antibodies used were: Cy3 anti-
rabbit (Jacksson) and Alexa 488 anti-guinea pig (Molecu-
lar Probes).
In situ hybridization
In situ hybridization was performed as described [9].
Probes used were: Ptf1a/p48  (provided by O. Hagen-
büchle), Sox9 (covering region 1365–2305 bp of image
clone 5320371) and Spon1 (covering region 1237–4035
bp of image clone 4221758).
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